Table II:
Permanent Atrial Fibrillation Cohort Descriptive Statistics, 2009–2013 (N=830,392)
| Number bene-quarters (in millions) | Percent | |
|---|---|---|
| PATIENT CHARACTERISTICS | ||
| Age group | ||
| 65–74 | 0.19 | 23.0 |
| 75–84 | 0.37 | 44.9 |
| 85+ | 0.27 | 32.1 |
| Sex | ||
| Male | 0.32 | 38.1 |
| Female | 0.51 | 61.9 |
| Non-white race/ethnicity | 0.07 | 8.6 |
| Black | 0.03 | 3.4 |
| Asian | 0.01 | 1.3 |
| Hispanic | 0.03 | 3.3 |
| Other non-Hispanic, non-white | <0.01 | 0.6 |
| Lives in socioeconomically disadvantaged zip code | 0.16 | 19.9 |
| Dually Eligible for Medicare & Medicaid | 0.21 | 25.0 |
| Lives in non-metropolitan county | 0.17 | 19.9 |
| Mean (Standard Deviation) | ||
| Charlson comorbidity score | 1.97 (2.19) | |
| PROVIDER CHARACTERISTICS | ||
| Provider age group | ||
| Under 65 | 0.70 | 84.0 |
| 65 or older | 0.13 | 16.0 |
| Provider sex | ||
| Male | 0.71 | 85.5 |
| Female | 0.12 | 14.5 |
| Provider Specialty | ||
| Primary Care | 0.40 | 47.9 |
| Cardiology | 0.39 | 47.2 |
| All other specialties | 0.41 | 4.9 |
| DRONEDARONE USE | ||
| All years | 0.021 | 2.5 |
| 2009 | 0.000 | 0.0 |
| 2010 | 0.005 | 3.0 |
| 2011 | 0.006 | 3.8 |
| 2012 | 0.005 | 2.9 |
| 2013 | 0.005 | 2.5 |